Status:
UNKNOWN
Endothelial Dysfunction in Covid-19
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Covid19
Hypoxemic Respiratory Failure
Eligibility:
All Genders
18-75 years
Brief Summary
SARS-CoV-2 targets endothelial cells via the angiotensin-converting enzyme 2 receptor. The specific impact of the resulting endothelial injury is currently unknown but may contribute to the pro-coagul...
Detailed Description
We prospectively compared clinical and biological parameters in ICU- and non-ICU-admitted Covid-19 patients, ICU-admitted patients with septic shock unrelated to Covid-19 and matched control subjects....
Eligibility Criteria
Inclusion
- positive result on a reverse-transcriptase-polymerase chain reaction testing performed on nasopharyngeal swab at hospital admission
Exclusion
- ICU admission more than five days after admission on a general ward,
- concomitant bacterial infection
- older than 75 years
- cirrhosis
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT04830683
Start Date
April 27 2020
End Date
April 1 2021
Last Update
April 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires Saint Luc
Brussels, Belgique, Belgium, 1040